People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DiCE MOLECULES HOLDINGS, LLC | — | Other Technology | Series C | $158.8M | $1.3B | 2018 |
| Tolerion, Inc. | — | Biotechnology | Series B | $43.0M | $793.8M | 2017 |
Stephen Zachary at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Zachary on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Rubin | 1 | 8 |
| John Donovan | 1 | 8 |
| Paul Manning | 1 | 6 |
| Jake Simson | 1 | 6 |
| Sean Stalfort | 1 | 5 |
| Shaan Gandhi | 1 | 4 |
| Richard Scheller | 1 | 4 |
| Lawrence Steinman | 1 | 4 |
| Sharon Tetlow | 1 | 4 |
| Scott Robertson | 1 | 3 |
| Kevin Judice | 1 | 3 |
| John Bedbrook | 1 | 3 |
| James Stutz | 1 | 2 |
| Jim Scopa | 1 | 2 |
| Alexander Fleming | 1 | 2 |
| Pehr Harbury | 1 | 2 |
| Michael Rabson | 1 | 2 |
| Graeme Curie | 1 | 1 |
| Scott Geyer | 1 | 1 |
| Randolph Johnson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.